As William Miller, CEO of Villya Pharmaceuticals and inventor of our patented technology (WO 2025/064695 A1), I appreciate the discussion around Lillys groundbreaking work in the GLP-1 space
Given the mix of medications, its difficult to parse out whether the weight loss can be attributed to the combination of phentermine and semaglutide, just one of those medications, or the complete mix of medications and dietary changes
Potent upstream regulator of the HPG axis
People who are allergic to Liraglutide or any of its ingredients Anyone living with multiple endocrine neoplasia syndrome type 2 (MEN 2) Those who are pregnant or trying to get pregnant Anyone actively breastfeeding People with a history of pancreatitis Those with serious kidney problems If you have any of these conditions, speak with your medical provider before starting Liraglutide
Kojonazarov, B., Myrzaakhmatova, A., Sooronbaev, T., Ishizaki, T
We encourage all patients to discuss the regulatory status of any peptide with our providers before starting a program
